急性心肌梗死临床治疗效果分析

Analysis of treatment outcomes in acute myocardial infarction

目的具体总结现阶段急性心肌梗死临床治疗方法、效果,为急性心肌梗死临床治疗工作提供参考。方法回顾分析我院收治治疗的40例急性心肌梗死患者的临床资料,按照临床药物治疗方式的不同,将其分为对照组(硝酸甘油静滴、低分子肝素钙皮下注射、阿司匹林口服)和观察组(对照组基础上联合尿激酶静脉滴注溶栓治疗)两组。比较两组患者的临床疗效、并发症发生情况以及临床症状变化时间。结果对两组患者的临床观察指标进行统计,经分析证实观察组患者总体治疗效果优于对照组,P<0.05。结论对于急性心肌梗死患者来说,行尿激酶、低分子肝素钙联合应用效果显著,能够提高总体治疗效果,降低并发症的发生比例,具有推广应用价值。

Objective To summarize the method and effect of current clinical treatment of acute myocardial infarction and to provide reference for clinical treatment of acute myocardial infarction. Methods A retrospective analysis was performed on the clinical data of 40 patients with acute myocardial infarction who were admitted to our hospital. These patients were divided into control group and observation group. The control group received an intravenous drip of nitroglycerin, subcutaneous injection of low-molecular-weight heparin calcium, and oral aspirin. The observation group received thrombolysis by an intravenous drip of urokinase in addition to the therapy for the control group. The two groups were compared in terms of treatment outcomes, complications, and changes in clinical symptoms. Results Results The observation group had a significantly better overall treatment outcome than the control group （P〈0.05）, according to the statistical analysis of clinical indices. Conclusion Urokinase combined with low-molecular-weight heparin calcium can produce an improved overall treatment outcome and reduce the incidence of complications in patients with acute myocardial infarction and hold promise for clinical application.